Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
RESEARCH TOOLSreports
Holding DE:640?
Track your performance easily
640 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.52 - €0.84
Previous Close€0.67
Volume0.00
Average Volume (3M)1.67K
Market Cap
€4.24B
Enterprise Value€10.62B
Total Cash (Recent Filing)HK$60.23B
Total Debt (Recent Filing)HK$70.56B
Price to Earnings (P/E)8.3
Beta0.04
Next Earnings
Aug 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 10, 2024Dividend Yield4.63%
Share Statistics
EPS (TTM)0.08
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume1,666
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.17
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.91Price Target Upside36.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
China Resources Pharmaceutical Group Ltd. News
PremiumCompany Announcements
China Resources Pharmaceutical Completes Green Cross HK Acquisition
PremiumCompany Announcements
China Resources Subsidiary Reports Revenue Surge Amid Cash ChallengesPremiumCompany Announcements
China Resources Sanjiu Reports Rising Profits Despite Cash Decline
PremiumCompany Announcements
Jiangzhong Pharmaceutical Sees Profit Growth Amid Revenue Dip
PremiumCompany Announcements
China Resources Reports KPC’s Nine-Month Financials
PremiumCompany Announcements
China Resources Double-Crane Reports Modest Gains Amid Challenges
PremiumCompany Announcements
CR Boya’s Financials Show Revenue Dip, Cash Boost
PremiumCompany Announcements
China Resources Plans Shareholding Boost in JiangzhongOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.46% Mutual Funds
― Other Institutional Investors
96.17% Public Companies and
Individual Investors
640 FAQ
What was China Resources Pharmaceutical Group Ltd.’s price range in the past 12 months?
China Resources Pharmaceutical Group Ltd. lowest stock price was €0.52 and its highest was €0.83 in the past 12 months.
What is China Resources Pharmaceutical Group Ltd.’s market cap?
Currently, no data Available
When is China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date?
China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 280 days.
How were China Resources Pharmaceutical Group Ltd.’s earnings last quarter?
Currently, no data Available
Is China Resources Pharmaceutical Group Ltd. overvalued?
According to Wall Street analysts China Resources Pharmaceutical Group Ltd.’s price is currently Undervalued.
Does China Resources Pharmaceutical Group Ltd. pay dividends?
China Resources Pharmaceutical Group Ltd. pays a Annually dividend of €0.01 which represents an annual dividend yield of 4.63%. See more information on China Resources Pharmaceutical Group Ltd. dividends here
What is China Resources Pharmaceutical Group Ltd.’s EPS estimate?
China Resources Pharmaceutical Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Resources Pharmaceutical Group Ltd. have?
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding.
What happened to China Resources Pharmaceutical Group Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of China Resources Pharmaceutical Group Ltd.?
Currently, no hedge funds are holding shares in DE:640
---
China Resources Pharmaceutical Group Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.22%
Trailing 12-Months
Company Description
China Resources Pharmaceutical Group Ltd.
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. The company's estimated operating income is approximately 56% distribution, 43% manufacturing, and less than 1% retail pharmacies.
---
640 Stock 12 Month Forecast
Average Price Target
€0.91
▲(36.84% Upside)
Technical Analysis
Best Analysts Covering 640
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+18.30%
reiterated a buy rating 2 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.30% per trade.
---